Eric Topol· @EricTopol · X·· 4 小时前AI 评分22
AI 导读
工程化T细胞用于癌症免疫治疗，在某些类型中已取得显著成功。但下一代疗法正在酝酿中，正如今天@Cancer_Cell上发表的综述所述，这应当有助于将该领域进一步推进到实体瘤。 https://www.cell.com/cancer-cell/fulltext/S1535-6108(26)00424-1
正文
Engineering T cells for immunotherapy vs cancer had already had marked success in certain types. But there's a next generation in the hopper, as reviewed today @Cancer_Cell, that ought to help take the field much further into solid tumors
https://www.cell.com/cancer-cell/fulltext/S1535-6108(26)00424-1
来源：Eric Topol · x.com